Cis-Vaccenic acid-d13
Cis-Vaccenic acid-d13 is the deuterium labeled cis-Vaccenic acid. cis-Vaccenic acid, the antiviral extract from Rhodopseudomonas capsulate and the predominant active component of Rhodopseudomonas capsulate[1], acts a potential fetal hemoglobin inducer[2].
Product Specifications
UNSPSC
12352211
Target
Antibiotic
Type
Isotope-Labeled Compounds
Related Pathways
Anti-infection
Field of Research
Cancer
Solubility
10 mM in DMSO
Smiles
OC(CCCCCCCCC/C=C\C([2H])(C([2H])(C([2H])(C([2H])(C([2H])(C([2H])([2H])[2H])[2H])[2H])[2H])[2H])[2H])=O
Molecular Formula
C18H21D13O2
Molecular Weight
295.54
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]H Hirotani, et al. Inactivation of T5 phage by cis-vaccenic acid, an antivirus substance from Rhodopseudomonas capsulata, and by unsaturated fatty acids and related alcohols. FEMS Microbiol Lett. 1991 Jan 1;61 (1) :13-7.|[3]Idowu A Aimola, et al. Cis-vaccenic acid induces differentiation and up-regulates gamma globin synthesis in K562, JK1 and transgenic mice erythroid progenitor stem cells. Eur J Pharmacol. 2016 Apr 5;776:9-18.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A06890-2-PE 100 µg/Vial
Anti-Dynamin 3/DNM3 Antibody Picoband®, PE Conjugate
Sign In for Pricing
View Details 
TXB38869-01 50 mg
1- (7-Bromo-2,3-dihydro-1,4-benzodioxin-6-yl) ethan-1-amine hydrochloride
Sign In for Pricing
View Details TXB38869-02 0.5 g
1- (7-Bromo-2,3-dihydro-1,4-benzodioxin-6-yl) ethan-1-amine hydrochloride
Sign In for Pricing
View Details